Returning users sign-in here.

 

                  

Today, understanding the global regulatory pathway for new medical technologies is critical when making product development and commercialization decisions. With this exclusive offer, Qmed users can try the US Regulatory Calculator for free or generate a complete InnoVision™ Report at a highly discounted price.

The free US Regulatory Calculator provides the potential FDA pathway for your medical technology. In minutes you'll receive the likely regulatory FDA classification and product codes for medical devices in Cardiovascular, Orthopedic, Gastroenterology & Urology, General/Plastic Surgery or Radiological technology.

View a Free Sample US Regulatory Report

For a more comprehensive regulatory view, use the full version of the e-Zassi InnoVision™ tool where you'll be able to generate a detailed product analysis that includes both US and EU regulatory classifications.

With this information you will be able to instantly compare both marketplaces, a key component of being able to decide where it's more favorable to test or launch new products first. The report also generates other pivotal development and commercialization data points such as end-user call pattern, reimbursement, manufacturing and clinical status.

View a Sample InnoVision Report




Now available to Qmed readers
for only $500, this report is normally
priced at $1,750.

e-Zassi software does not utilize any confidential information, allowing you to share your reports with business partners and vendors, regardless of the patent status or confidentiality agreements. Now in a fraction of the time and costs typically needed, you'll get powerful insights into critical product development hurdles, enabling you to make more informed decisions about your medical technology.

If there is someone else in your organization that would like to receive this information, let us know.
For questions or technical support contact e-Zassi Customer Support at 866-369-5170.

 

© 2011 e-Zassi, LLC. All Rights Reserved.